Characterizing the Network of Drugs and Their Affected Metabolic Subpathways

A fundamental issue in biology and medicine is illustration of the overall drug impact which is always the consequence of changes in local regions of metabolic pathways (subpathways). To gain insights into the global relationship between drugs and their affected metabolic subpathways, we constructed a drug–metabolic subpathway network (DRSN). This network included 3925 significant drug–metabolic subpathway associations representing drug dual effects. Through analyses based on network biology, we found that if drugs were linked to the same subpathways in the DRSN, they tended to share the same indications and side effects. Furthermore, if drugs shared more subpathways, they tended to share more side effects. We then calculated the association score by integrating drug-affected subpathways and disease-related subpathways to quantify the extent of the associations between each drug class and disease class. The results showed some close drug–disease associations such as sex hormone drugs and cancer suggesting drug dual effects. Surprisingly, most drugs displayed close associations with their side effects rather than their indications. To further investigate the mechanism of drug dual effects, we classified all the subpathways in the DRSN into therapeutic and non-therapeutic subpathways representing drug therapeutic effects and side effects. Compared to drug side effects, the therapeutic effects tended to work through tissue-specific genes and these genes tend to be expressed in the adrenal gland, liver and kidney; while drug side effects always occurred in the liver, bone marrow and trachea. Taken together, the DRSN could provide great insights into understanding the global relationship between drugs and metabolic subpathways.

[1]  O. Kocaman,et al.  Clindamycin-induced acute cholestatic hepatitis. , 2007, World journal of gastroenterology.

[2]  R. Daum,et al.  Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. , 2007, The New England journal of medicine.

[3]  M. Cooke,et al.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate , 2010, Nature Reviews Immunology.

[4]  J. Korf,et al.  Tryptophan as a Link between Psychopathology and Somatic States , 2003, Psychosomatic medicine.

[5]  J. Cuppoletti,et al.  Activation Of Human Clc‐2 Cl– Channels: Implications For Cystic Fibrosis , 2000, Clinical and experimental pharmacology & physiology.

[6]  Andrew L. Hopkins,et al.  Drug discovery: Predicting promiscuity , 2009, Nature.

[7]  C. Ulrich,et al.  Pharmacogenetics of folate-related drug targets in cancer treatment. , 2005, Pharmacogenomics.

[8]  D. Kell.  Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.

[9]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[10]  David M. Wilson,et al.  Network biology as a new approach to drug discovery. , 2010, Current opinion in drug discovery & development.

[11]  Jong-Hwan Lee,et al.  Calcium and neostigmine antagonize gentamicin, but augment clindamycin-induced tetanic fade in rat phrenic nerve-hemidiaphragm preparations , 2008, Journal of Anesthesia.

[12]  Ravi Iyengar,et al.  Network analyses in systems pharmacology , 2009, Bioinform..

[13]  Yongyuth Yuthavong,et al.  Folate metabolism as a source of molecular targets for antimalarials. , 2006, Future microbiology.

[14]  Xia Li,et al.  A sub-pathway-based approach for identifying drug response principal network , 2011, Bioinform..

[15]  S. Ahlstedt,et al.  Antazoline-induced immune hemolytic anemia, hemoglobinuria, and acute renal failure. , 2009, Acta medica Scandinavica.

[16]  Satoru Miyano,et al.  Identifying drug active pathways from gene networks estimated by gene expression data. , 2005, Genome informatics. International Conference on Genome Informatics.

[17]  M. L. Greenberg,et al.  Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs. , 2002, Bipolar disorders.

[18]  M. Dowsett,et al.  Influence of sex hormones on cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Yun Xiao,et al.  MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.

[20]  I. Pérez-Torres,et al.  Sex hormones, metabolic syndrome and kidney. , 2011, Current topics in medicinal chemistry.

[21]  Bernhard O Palsson,et al.  Hierarchical thinking in network biology: the unbiased modularization of biochemical networks. , 2004, Trends in biochemical sciences.

[22]  A. Shirwaikar,et al.  Antiinflammatory and antiulcer activities of phytic acid in rats. , 2004, Indian journal of experimental biology.

[23]  G. Ramakrishnan,et al.  Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. , 2010, European journal of pharmacology.

[24]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[25]  Bin Chen,et al.  Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..

[26]  Daniel C. Liebler,et al.  Elucidating mechanisms of drug-induced toxicity , 2005, Nature Reviews Drug Discovery.

[27]  Zhongyuan Xiang,et al.  Clinical significance of simultaneous determination of serum tryptophan and tyrosine in patients with lung cancer , 2011, Journal of clinical laboratory analysis.

[28]  T. Nakanishi,et al.  Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by a Coptidis Rhizoma Extract and Protoberberine Alkaloids , 2002, Bioscience, biotechnology, and biochemistry.

[29]  A. Fliri,et al.  Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.

[30]  V. Parikh,et al.  Antipsychotic drugs differentially modulate apolipoprotein D in rat brain , 2003, Journal of neurochemistry.

[31]  C. Le Jeunne,et al.  [Drug-induced gynecomastia]. , 2000, Annales de medecine interne.

[32]  Chunquan Li,et al.  The Implications of Relationships between Human Diseases and Metabolic Subpathways , 2011, PloS one.

[33]  L. Schiffmann,et al.  Colon perforation with acute peritonitis after taking clindamycin and diclofenac following wisdom tooth removal. , 2004, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[34]  A. Brix,et al.  Comparative Hepatic Toxicity: Prechronic/Chronic Liver Toxicity in Rodents , 2005, Toxicologic pathology.

[35]  R. Bazinet,et al.  Regulation of brain polyunsaturated fatty acid uptake and turnover. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[36]  Wei Li,et al.  Dissection of human MiRNA regulatory influence to subpathway , 2012, Briefings Bioinform..

[37]  M. Coroneo,et al.  Hypersensitivity reaction to intravitreal clindamycin therapy , 2002, Clinical & experimental ophthalmology.

[38]  Christoph H Borchers,et al.  Effect of Antibiotic Treatment on the Intestinal Metabolome , 2011, Antimicrobial Agents and Chemotherapy.

[39]  C. Baudry,et al.  Differential effects of steroids on the synthesis of polyunsaturated fatty acids by human neuroblastoma cells , 2009, Neurochemistry International.

[40]  J. Łuszczki,et al.  Effect of histamine receptor antagonists on aminophylline-induced seizures and lethality in mice. , 2005, Pharmacological reports : PR.

[41]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[42]  S. Szabó,et al.  Adrenal Gland: Chemically Induced Structural and Functional Changes in the Cortex , 1989, Toxicologic pathology.

[43]  C. Ulrich,et al.  Pharmacogenetics and folate metabolism -- a promising direction. , 2002, Pharmacogenomics.

[44]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[45]  Justin A. Ionita,et al.  Metabolic networks: enzyme function and metabolite structure. , 2004, Current opinion in structural biology.

[46]  Jean-Marc Schwartz,et al.  A global view of drug-therapy interactions , 2007, BMC pharmacology.

[47]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[48]  Andrey Rzhetsky,et al.  Quantitative systems-level determinants of human genes targeted by successful drugs. , 2008, Genome research.

[49]  M. Wacker,et al.  Inhibition of Thromboxane A2-Induced Arrhythmias and Intracellular Calcium Changes in Cardiac Myocytes by Blockade of the Inositol Trisphosphate Pathway , 2009, Journal of Pharmacology and Experimental Therapeutics.

[50]  L. Mucke,et al.  Phospholipase A2 and arachidonic acid in Alzheimer's disease. , 2010, Biochimica et biophysica acta.

[51]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[52]  M. Oti,et al.  The modular nature of genetic diseases , 2006, Clinical genetics.

[53]  A. Fliri,et al.  Analysis of System Structure–Function Relationships , 2007, ChemMedChem.

[54]  Shi-Hua Zhang,et al.  Disease-Aging Network Reveals Significant Roles of Aging Genes in Connecting Genetic Diseases , 2009, PLoS Comput. Biol..

[55]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[56]  Y. Ozkan,et al.  In Vitro and Ex Vivo Permeation Studies of Etodolac from Hydrophilic Gels and Effect of Terpenes as Enhancers , 2007, Drug delivery.

[57]  Giulio Superti-Furga,et al.  A Computational Approach to Analyze the Mechanism of Action of the Kinase Inhibitor Bafetinib , 2010, PLoS Comput. Biol..

[58]  R. Daum.  Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus , 2007 .

[59]  Simone Rossi,et al.  Australian Medicines Handbook , 2012 .

[60]  Dragos Horvath,et al.  Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.

[61]  K. Inoue,et al.  Effect of anti-inflammatory agent etodolac on antigen-induced contractions of the trachea and lung parenchyma of guinea pigs. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.

[62]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[63]  Alan L. Miller,et al.  Epidemiology, etiology, and natural treatment of seasonal affective disorder. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[64]  J. Nacher,et al.  Modularity in Protein Complex and Drug Interactions Reveals New Polypharmacological Properties , 2012, PloS one.

[65]  J. Derrick,et al.  The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[66]  M. Kanehisa,et al.  Network analysis of adverse drug interactions. , 2008, Genome informatics. International Conference on Genome Informatics.

[67]  Chunquan Li,et al.  SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.

[68]  Bin Song,et al.  Mining Metabolic Networks for Optimal Drug Targets , 2007, Pacific Symposium on Biocomputing.

[69]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[70]  Xia Li,et al.  Identification of pathways involved in paclitaxel activity in cervical cancer. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[71]  J. Castle,et al.  Definition, conservation and epigenetics of housekeeping and tissue-enriched genes , 2009, BMC Genomics.

[72]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[73]  E. Levanon,et al.  Human housekeeping genes are compact. , 2003, Trends in genetics : TIG.

[74]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[75]  Weiya Ma,et al.  PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer. , 1999, Anticancer research.

[76]  R. Guimerà,et al.  Functional cartography of complex metabolic networks , 2005, Nature.

[77]  M. Vidal,et al.  Networking metabolites and diseases , 2008, Proceedings of the National Academy of Sciences.

[78]  Guanghui Hu,et al.  Human Disease-Drug Network Based on Genomic Expression Profiles , 2009, PloS one.

[79]  Tudor I. Oprea,et al.  Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer‐Aided Drug Repurposing , 2011, Molecular informatics.

[80]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.